Furthermore, the ectopic overexpression of X-linked inhibitor of apoptosis protein (XIAP) promotes the degradation of YTHDC1, whereas genetic ablation of XIAP elevates YTHDC1 expression, thereby suppressing metastatic progression in bladder cancer. The gene discussed is XIAP; the disease is urinary bladder cancer.